August 28, 2022
FX1a inhibitors tested in 2 stroke trials
PHRI researchers presented results from phase-2 stroke trials testing different orally active coagulation Factor X1a (FXIa) inhibitors in patients with...
Read MoreAugust 28, 2022
PHRI researchers presented results from phase-2 stroke trials testing different orally active coagulation Factor X1a (FXIa) inhibitors in patients with...
Read MoreAugust 26, 2022
The joy of in-person camaraderie and collaboration was apparent in everyone’s faces during two days of PHRI-hosted meetings with our...
Read MoreAugust 23, 2022
During the COVID-19 pandemic to date, PHRI has been forging ahead – completing major studies, publishing in high-impact journals, and...
Read MoreAugust 22, 2022
We are delighted to welcome a new Investigator and three new Research Fellows to PHRI! New Investigator, Rachel Eikelboom, is a...
Read MoreAugust 18, 2022
A sign of good leadership is understanding what’s important to your employees, and then investing to make that happen. As...
Read MoreAugust 9, 2022
It is Indigenous Peoples Day globally, and we wish to thank our Indigenous partners in research in Canada. We are...
Read MoreBack To Top